✦ LIBER ✦

Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C

✍ Scribed by Gabriele Zoppoli; Giovanni Di Maio; Stefania Artioli; Cristina Robaudo; Monica Basso; Francesco Torre; Giuseppe Cannella; Antonino Picciotto

Publisher: Wiley (John Wiley & Sons)
Year: 2008
Tongue: English
Weight: 89 KB
Volume: 37
Category: Article
ISSN: 0090-2934
DOI: 10.1002/dat.20219

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon alpha-2b as monothe

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta

✍ Grazia Anna Niro; Alessia Ciancio; Giovanni Battista Gaeta; Antonina Smedile; Al 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

Mutations in the interferon sensitivity-

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy

✍ Kazuhiko Hayashi; Yoshiaki Katano; Takashi Honda; Masatoshi Ishigami; Akihiro It 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is thought to be inhibited by the double‐stranded RNA‐dependent protein kinase (PKR). Several studies have reported a relationship between the ISDR and interferon (IFN) responsiveness. However, this relationship is controversial. The

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues

✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of

Pegylated interferon monotherapy of chro

Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials

✍ Fabrizio Fabrizi; Vivek Dixit; Piergiorgio Messa; Paul Martin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Abstract The efficacy and safety of pegylated interferon monotherapy in patients with chronic renal failure and chronic hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue. A systematic review of the literature with a meta‐analysis of

Pleural effusion associated with pegylat

Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C

✍ Amit Arora; Leonardo Vargas; Tomasz J. Kuzniar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52‐year‐old woman, who developed pneumonitis with exudative, lymphocytic‐predominant pleural effusion following

Treatment of chronic hepatitis E in live

Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b

✍ Elizabeth B. Haagsma; Annelies Riezebos-Brilman; Arie P. van den Berg; Robert J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Hepatitis E virus (HEV) infections are known to run a self-limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid-organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is curren